Cellbricks

At Cellbricks, we are committed to make a significant impact on the lives of millions of patients dealing with compromised organ function. We achieve this through the innovative production of bioprinted tissue therapeutics, offering humans longer and healthier lives by restoring or supporting organ function. Cellbricks is a biotech company, combining world-leading expertise in synthetic biology and 3D-bioprinting. Leveraging our proprietary biofabrication technology and our tissue engineering proficiency, we are replicating human tissue at scale so researchers and doctors can provide patients with better clinical treatments. Our rapidly growing, multi-disciplinary team consists of biotech enthusiasts, scientists, PhDs, engineers, chemists and...

3d bioprinting,bioink,biotechnology,tissue engineering,breast cancer,regenerative medicine,labmodels,recombinant collagen,techbio,oncology,pharma,lifesciences,healthtech,biologics,implants,autologous tissue implants,breast reconstruction,stereolithography,human tissue,and tissue therapeutics

Cellbricks operates in the Biotechnology industry.

Cellbricks's revenue is 11m - 100m

Cellbricks has 11 - 50 employees.